For the treatment of primary hypercholesterolemia, mixed dyslipidemia, and severe hypertriglyceridemia as adjunctive therapy to diet

ANTARA® provides beneficial effects across key lipid parameters when taken once daily with or without food1

37% reduction in TG
8% reduction in non-HDL-C
14% increase in HDL-C1
  1. Davidson MH, Bays H, Rhyne J, et al. Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study. Clin Ther. 2005;27(6):715-727.
  2. ANTARA® Prescribing Information.